Condition

Breast Cancer With Low to Intermediate HER2 Expression (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Galena Biopharma, Inc. (1)

Collaborator

Intervention

leukine® (sargramostim, gm-csf) and water for injection (1)

neuvax™ vaccine (1)

Study Documents

Intervention Type

biological (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

breast cancer with low to intermediate her2 expression

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer With Low to Intermediate HER2 Expression Trial in Worldwide (NeuVax™ vaccine, Leukine® (sargramostim, GM-CSF) and

Completed

Breast Cancer With Low to Intermediate HER2 Expression

NeuVax™ vaccine
Leukine® (sargramostim, GM-CSF) and water for injection

Bessemer, Alabama
+196 more

Feb 23, 2017